Nigeria: Publication of Financial Sector Assessment Program ...
GSK Nigeria financial report 2015
96
-
Upload
michael-olafusi -
Category
Investor Relations
-
view
34 -
download
2
Transcript of GSK Nigeria financial report 2015
-
Corporate Report Financial Statements
Consolidated and Separate Statement of Financial PositionFor the year ended 31 December 2015
The accompanying notes on pages 35 to 69 and non-IFRS statements on pages 70 to 72 form an integral part of these consolidated and separate financial statements.
The consolidated and separate financial statements on pages 31 to 72 were approved and authorised for issue by the Board of Directors on 9 March 2016 and signed on its behalf by:
Mr. Edmund C. OnuzoChairmanFRC/2015/IODN/00000011038
Mr. Dayanand Thandalam Sriram
FRC/2014/IODN/00000010391Managing Director
Mr. Nelson A. Sanni (FCA)Head, Corporate ReportingFRC/2013/ICAN/00000004921
AssetsNon-current assetsProperty, plant and equipment 15
Other assets
Investment in subsidiary 16
19
Inventories 17
Trade and other receivables 18
Cash and bank balances 20
Other assets 19
Total assets
Equity and liabilities
Equity
Equity
Issued share capital 21
Share premium 21
Retained earnings
Total equity
Non-current liabilitiesRetirement benefit obligations 25
Deferred tax liabilities 13
Total non-current liabilities
Trade and other payables 26
Income tax payable 13
Total liabilities
Total equity and liabilities
13,751,342
122,900
_
7,418,238
6,236,265
3,638,323
17,455,471
162,645
31,329,713
597,939
51,395
12,535,880
13,185,214
169,245
1,843,865
2,013,110
15,725,770
405,619
16,131,389
18,144,499
31,329,713
13,419,394
63,266
_
7,589,550
4,977,242
1,696,512
14,510,208
246,904
27,992,868
478,351
51,395
12,418,498
12,948,244
130,975
1,692,834
1,823,809
11,891,919
1,328,896
13,220,815
15,044,624
27,992,868
13,751,342
122,900
160
7,418,238
6,236,265
3,430,314
17,247,462
162,645
31,121,864
597,939
51,395
12,345,132
12,994,466
169,245
1,843,865
2,013,110
15,722,973
391,315
16,114,288
18,127,398
31,121,864
13,419,394
63,266
160
7,589,550
4,977,242
244,722
1,494,704
14,306,218
27,789,038
478,351
51,395
12,236,482
12,766,228
130,975
1,692,834
1,823,809
11,889,115
1,309,886
13,199,001
15,022,810
27,789,038
13,874,242 13,482,660 13,874,402 13,482,820Current assets
Current liabilities
Note
GROUP
2015 N000
COMPANY
N000 2014
N000 2015
N000 2014
Total current liabilities
Investors Information
GSK Annual Report & Financial Statements 2015 32
-
Board of Directors of GlaxoSmithKl ine Consumer Niger ia PLC.
-
Board of Directors of GlaxoSmithKl ine Consumer Niger ia PLC.
-
87
-
89
-
GSK Annual Report & Financial Statements 2015 91
-
Page 1Page 2Page 3Page 4Page 5Page 6Page 7Page 8Page 9Page 10Page 11Page 12Page 13Page 14Page 15Page 16Page 17Page 18Page 19Page 20Page 21Page 22Page 23Page 24Page 25Page 26Page 27Page 28Page 29Page 30Page 31Page 32Page 33Page 34Page 35Page 36Page 37Page 38Page 39Page 40Page 41Page 42Page 43Page 44Page 45Page 46Page 47Page 48Page 49Page 50Page 51Page 52Page 53Page 54Page 55Page 56Page 57Page 58Page 59Page 60Page 61Page 62Page 63Page 64Page 65Page 66Page 67Page 68Page 69Page 70Page 71Page 72Page 73Page 74Page 75Page 76Page 77Page 78Page 79Page 80Page 81Page 82Page 83Page 84Page 85Page 86Page 87Page 88Page 89Page 90Page 91Page 92Page 93Page 94Page 95Page 96
